Who We Are: MapLight Therapeutics is a clinical stage biotech company that focuses on drug discovery for central nervous system disorders. We combine cutting-edge technologies including optogenetics, in vivo physiology, and spatial transcriptomics to identify novel drug targets and develop effective therapies to address psychiatric symptoms.
What You’ll Do:
We are seeking a motivated and talented Associate Director to join the formulation development group in the CMC department. Reporting to the Director of Formulation Development, the desired candidate will lead drug product development initiatives in collaboration with external CDMOs for MapLight’s pipeline programs. This is a great opportunity to join a small team and grow in a fast-paced environment to bring drug products from initial concept to patients.
Responsibilities:
Qualifications:
Location:
Travel:
Compensation for this role may vary within the above range based on many factors including geographic location, candidate experience, and skills. Additional compensation/benefits include annual bonus opportunity, medical, dental, vision, life and AD&D, short term and long term disability, 401(K) plan with match, stock options, flexible non-accrual paid time off, and parental leave.
EEOC Statement: MapLight Therapeutics is an equal opportunity employer, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, sexual orientation, gender identity, disability status, protected veteran status, or any other characteristic protected by law.
Work on cutting-edge sports data and analytics. Join a team that's revolutionizing how we understand sports performance with AI and machine learning.
Interested in building your career at Maplight Therapeutics? Get future opportunities sent straight to your email.
Create AlertDiscover similar positions that might interest you
Maplight Therapeutics
Maplight Therapeutics
Maplight Therapeutics
Maplight Therapeutics
Maplight Therapeutics
Maplight Therapeutics